Glioblastoma multiforme is an aggressive brain tumor that mainly affects adults. Approximately 30,000 people in the U.S. are ...

Telix reports early Phase 2 data showing TLX101 improves survival in recurrent brain cancer patients, with no serious side effects observed.

Teddi Mellencamp posted a video of herself ringing a bell in the hospital to mark the end of her radiation treatment after ...

For many cancer patients, side effects from radiation can be debilitating. But a new way of delivering radiation treatment ...

In a recent study published in Small, researchers at the University of Michigan developed nanodiscs designed to target ...

For many cancer patients, side effects from radiation can be debilitating. But a new way of delivering radiation treatment has proven effective at eliminating a hard-to-treat cancer with the only side ...

Telix Pharmaceuticals Limited (NASDAQ:TLX) on Tuesday released preliminary results from the Phase 2 IPAX-Linz study of TLX101 (131I-iodofalan1) in recurrent high-grade glioma (brain cancer ...

Artificial intelligence (AI) shows tremendous promise for analyzing vast medical imaging datasets and identifying patterns ...

B oth radiation and temozolomide, a generic chemotherapy treatment in pill form, have meaningful single-modality anti-tumor activity against slow-growing, low-grade gliomas. The randomized phase 3 ...

The FDA granted breakthrough therapy designation to an autologous CAR-T cell therapy for pediatric patients with diffuse ...